|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.010 CNY | +1.21% |
|
+6.82% | -2.15% |
| 06-11 | Jointown Pharma Issues 1 Billion Yuan in Asset-Backed Securities | MT |
| 06-03 | Jointown Pharmaceutical Unit Gets Nod to Market Allergy Symptoms Treatment | MT |
| Market Cap | 24.98B 3.67B 3.22B 2.97B 2.75B 5.21B 352B 5.31B 35.75B 13.89B 172B 13.79B 13.49B 597B | P/E 2026 * |
10.7x | P/E 2027 * | 9.88x |
|---|---|---|---|---|---|
| Enterprise Value | 20.66B 3.04B 2.66B 2.46B 2.27B 4.31B 291B 4.39B 29.56B 11.49B 142B 11.4B 11.15B 494B | EV / Sales 2026 * |
0.12x | EV / Sales 2027 * | 0.11x |
| Free-Float |
43.03% | Yield 2026 * |
4.17% | Yield 2027 * | 4.45% |
| 1 day | +1.21% | ||
| 1 week | +6.82% | ||
| Current month | +6.82% | ||
| 1 month | +0.80% | ||
| 3 months | -6.53% | ||
| 6 months | -4.39% | ||
| Current year | -2.15% |
| 1 week | 4.69 |  | 5.08 |
| 1 month | 4.48 | | 5.08 |
| Current year | 4.48 | | 5.84 |
| 1 year | 4.48 | | 5.84 |
| 3 years | 4.35 | | 6.94 |
| 5 years | 3.97 | | 6.94 |
| 10 years | 3.97 | | 8.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei He
CEO | Chief Executive Officer | 40 | 22/04/2022 |
Xiao Yi Xia
DFI | Director of Finance/CFO | 48 | 14/11/2023 |
Xi Zhang
IRC | Investor Relations Contact | - | 22/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gu Liang Tang
BRD | Director/Board Member | 64 | 04/11/2020 |
Bao Lin Liu
CHM | Chairman | 73 | 31/10/2008 |
Zhao Nian Liu
BRD | Director/Board Member | 66 | 15/11/2008 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.21% | +6.82% | -3.28% | -6.33% | 3.63B | |
| +1.13% | +6.19% | +12.63% | +96.64% | 94.52B | |
| -0.51% | +0.38% | +45.10% | +154.70% | 56.14B | |
| -0.71% | +1.82% | -7.28% | +241.46% | 22.5B | |
| 0.00% | +4.94% | -9.97% | -24.94% | 8.04B | |
| -1.03% | +2.88% | -27.02% | -36.57% | 7.54B | |
| +0.94% | +7.98% | -7.24% | -27.97% | 6.77B | |
| -0.50% | +1.35% | +22.72% | +35.22% | 6.42B | |
| -0.46% | +1.83% | -1.60% | +22.17% | 5.35B | |
| +1.14% | +4.96% | +18.98% | +19.11% | 3.44B | |
| Average | +0.01% | +2.75% | +4.30% | +47.35% | 21.44B | |
| Weighted average by Cap. | +0.22% | +3.06% | +15.96% | +107.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 170B 24.96B 21.89B 20.21B 18.68B 35.4B 2,390B 36.11B 243B 94.4B 1,169B 93.72B 91.67B 4,060B | 180B 26.43B 23.18B 21.4B 19.78B 37.49B 2,531B 38.24B 257B 99.97B 1,238B 99.26B 97.08B 4,299B |
| Net income | 2.36B 346M 304M 280M 259M 491M 33.16B 501M 3.37B 1.31B 16.23B 1.3B 1.27B 56.32B | 2.56B 376M 330M 305M 281M 533M 36.01B 544M 3.66B 1.42B 17.62B 1.41B 1.38B 61.17B |
| Net Debt | -4.32B -635M -557M -514M -475M -901M -60.81B -919M -6.18B -2.4B -29.76B -2.38B -2.33B -103B | -5.04B -741M -650M -600M -555M -1.05B -70.97B -1.07B -7.22B -2.8B -34.73B -2.78B -2.72B -121B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/07/26 | CN¥5.010 | +1.21% | 31,052,070 |
| 07/07/26 | CN¥4.950 | -1.98% | 43,125,289 |
| 06/07/26 | CN¥5.050 | +2.23% | 56,164,747 |
| 03/07/26 | CN¥4.940 | +1.86% | 52,076,136 |
| 02/07/26 | CN¥4.850 | +2.75% | 47,080,301 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600998 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
